歲寶百貨(00312.HK)擬出售珠海祥耀全部股權
格隆匯4月22日丨歲寶百貨(00312.HK)發佈公告,2025年4月22日,賣方(即賣方甲和賣方乙)與買方(即珠海市航夢時代科技有限公司)簽訂了股權轉讓協議,根據該協議,買方同意購入珠海市祥耀房地產開發有限公司(“珠海祥耀”)全部股權,購入價爲人民幣160萬元。
截至本公告日期,珠海祥耀由賣方甲(即深圳前海寶通電子商務有限公司)擁有90%及賣方乙(即深圳市慶壹信息諮詢有限公司)擁有10%。賣方甲爲公司的全資附屬公司,主要從事中國的貿易業務。賣方乙爲公司的全資附屬公司,主要在中國向集團的其他成員公司提供集團內部諮詢服務。珠海祥耀主要在中國從事房地產開發業務及爲珠海發展項目的擁有者及開發商。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.